Archive: 25/04/2014

Researchers generate immunity against tumor vessel protein

Sometimes a full-on assault isn't the best approach when dealing with a powerful enemy. A more effective approach, in the long run, may be to target the support system replenishing the supplies that keep your foe strong and ...

FDA reviews psychiatric side effects of Chantix

The U.S. Food and Drug Administration announced Friday it will convene a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer's anti-smoking drug Chantix.

Drugmaker developing abuse-deterrent painkiller

The San Diego company that makes the powerful new prescription painkiller Zohydro is selling off its migraine therapy business to focus on developing abuse-resistant forms of Zohydro.

WTO could rule on Australia anti-tobacco law this year

Attempts by tobacco-producing nations to sink Australia's landmark plain packaging law for cigarettes and cigars picked up pace Friday, as WTO members approved a broad probe on whether Canberra has broken the rules of global ...

page 1 from 4